How Zantac went from world's best-selling drug to being pulled from store shelves
Health authorities worldwide are investigating the safety of Zantac heartburn medicine, also sold generically as ranitidine, after finding a probable cancer-causing impurity in the drug. Here is a timeline on Zantac. (Source: CBC | Health)
Source: CBC | Health - October 22, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

What you should know if you take Zantac or ranitidine
If you take Zantac or its generic version, ranitidine, you may have noticed that you can't find it on the shelves at the pharmacy. That's because drug-makers recalled it due to safety concerns. The Food and Drug Administration is investigating the medication after discovering that some samples of ranitidine contain trace elements of N-nitrosodimethylamine (NDMA). [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 21, 2019 Category: Databases & Libraries Source Type: news

Zantac Recalled by Sanofi
MONDAY, Oct. 21, 2019 -- The over-the-counter heartburn drug Zantac (ranitidine) has been recalled in the United States and Canada by French drug maker Sanofi. The recall comes a month after the U.S. Food and Drug Administration first warned that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 21, 2019 Category: Pharmaceuticals Source Type: news

Timeline: Popular heartburn medicine Zantac pulled off store shelves
The U.S. Food and Drug Administration and international health authorities are investigating the safety of Zantac heartburn medicine, also sold generically as ranitidine, after finding a probable cancer-causing impurity in the drug. (Source: Reuters: Health)
Source: Reuters: Health - October 21, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Heartburn drug Zantac recalled in Canada, U.S. over contamination fears
Health Canada said it was investigating the possible presence of a carcinogen in some ranitidine drugs available by prescription and over-the-counter. (Source: CBC | Health)
Source: CBC | Health - October 19, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

Sanofi to conduct precautionary voluntary recall of Zantac OTC in U.S. and Canada
BRIDGEWATER, N.J., Oct. 18, 2019 -- (Healthcare Sales & Marketing Network) -- As a precautionary measure, Sanofi will conduct a voluntary recall of Zantac OTC (over-the-counter) in the U.S. and Canada. This recall is being taken due to possible contaminat... Biopharmaceuticals, Product Recall Sanofi, Zantac, ranitidine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 18, 2019 Category: Pharmaceuticals Source Type: news

Teva's UK arm recalls some batches of Ranitidine: Medicines watchdog
Teva Pharmaceutical's UK unit has recalled some batches of heartburn medicine Ranitidine, Britain's medicines watchdog said on Thursday, making it the latest drugmaker to pull the product. (Source: Reuters: Health)
Source: Reuters: Health - October 17, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Class 2 medicines recall: Ranitidine effervescent tablets 150mg and 300mg
Teva UK Limited trading as ratiopharm GmbH is recalling unexpired stock of Ranitidine effervescent tablets from pharmacies... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 17, 2019 Category: Drugs & Pharmacology Source Type: news

Pharmacy alert: oral ranitidine formulations supply disruption
The Department of Health and Social Care (DHSC) has advised of a disruption to supply of all oral formulations of ranitidine until further notice. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 16, 2019 Category: Drugs & Pharmacology Source Type: news